| Identification | More | [Name]
N-Methyl-L-alanine | [CAS]
3913-67-5 | [Synonyms]
H-L-MELLE-OH HCL
H-MEILE-OH HCL
H-MEILE-OH+ HCL
N-ALPHA-METHYL-L-ISOLEUCINE HYDROCHLORIDE
N-ME-ILE-OH HCL
N-METHYL-L-ISOLEUCINE HYDROCHLORIDE
Alanine, N-methyl-, L-
alpha-(Methylamino)propionic acid
L-Alanine, N-methyl-
L-N-Methylalanine
N-alpha-Methyl-L-alanine
N-Methyl-L-alanine
N-Methyl-L-aminopropanoic acid
N-METHYL-L-ISOLEUCINE HCL
(2S)-2-(Methylamino)propionic acid
(S)-2-(Methylamino)propionic acid
meAla | [EINECS(EC#)]
1533716-785-6 | [Molecular Formula]
C4H9NO2 | [MDL Number]
MFCD06801364 | [Molecular Weight]
103.12 | [MOL File]
3913-67-5.mol |
| Hazard Information | Back Directory | [Chemical Properties]
White to off-white powder | [Uses]
N-Methyl-L-alanine is a reactant used in the preparation of site-specific trastuzumab maytansinoid antibody-drug conjugates with improved therapeutic activity. | [Definition]
ChEBI: A methyl-L-alanine in which one of the the amino hydrogen of L-alanine is replaced by a methyl group. | [reaction suitability]
reaction type: solution phase peptide synthesis |
|
|